April 02, 2020 A Covid-19 threat to business acquisitions 20 key healthcare transactions, most struck before the Covid-19 pandemic hit, have yet to be formally completed.
July 20, 2018 Upcoming events – FDA decision for Progenics and Allergy comes out of hiding Progenics hopes to secure US approval for Azedra, while Allergy Therapeutics awaits phase III data with its birch vaccine.
